LivaNova (LIVN) Other Non-Current Assets (2015 - 2026)
LivaNova (LIVN) posted Other Non-Current Assets of $15.4 million for Q1 2026, down 2.05% sequentially from $15.7 million in Q4 2025, and up 10.7% YoY from $13.9 million in Q1 2025.
LivaNova (LIVN) Other Non-Current Assets (2015 - 2026) Analysis & Trends
LivaNova has reported Other Non-Current Assets for 12 years, with the latest figure at $15.4 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 10.7% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.4 million (up 10.7% YoY) and the FY2025 annual result came in at $15.7 million, up 11.02% from the prior year.
- Other Non-Current Assets retreated to $15.4 million in Q1 2026 per LIVN's latest filing, from $15.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $17.9 million in Q1 2022 and troughed at $12.1 million in Q4 2023.
- A 5-year average of $14.7 million and a median of $14.4 million in 2024 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 23.88% in 2022, down 73.44% in 2022.
- Over 5 years, Other Non-Current Assets stood at $16.2 million in 2022, then dropped by 25.68% to $12.1 million in 2023, then climbed by 17.15% to $14.1 million in 2024, then advanced by 11.02% to $15.7 million in 2025, then fell by 2.05% to $15.4 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $15.4 million, $15.7 million, and $14.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.85 Bn | 194.25 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.75 Bn | 126.28 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 119.86 Bn | 110.64 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.04 Bn | 73.50 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.51 Bn | 48.26 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.75 Bn | 32.81 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 215.10 Mn |
| 10 | LivaNova | 4.32 Bn | 3.81 Bn | 273.67 Mn | 18.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.31 Mn |
| Mar 31, 2026 | 15.37 Mn |
| Dec 31, 2025 | 15.69 Mn |
| Sep 30, 2025 | 14.80 Mn |
| Jun 30, 2025 | 14.33 Mn |
| Mar 31, 2025 | 13.88 Mn |
| Dec 31, 2024 | 14.13 Mn |
| Sep 30, 2024 | 14.37 Mn |
| Jun 30, 2024 | 14.36 Mn |
| Mar 31, 2024 | 13.37 Mn |
| Dec 31, 2023 | 12.06 Mn |
| Sep 30, 2023 | 12.12 Mn |
| Jun 30, 2023 | 13.48 Mn |
| Mar 31, 2023 | 13.95 Mn |
| Dec 31, 2022 | 16.23 Mn |
| Sep 30, 2022 | 16.54 Mn |
| Jun 30, 2022 | 17.14 Mn |
| Mar 31, 2022 | 17.92 Mn |
| Dec 31, 2021 | 13.10 Mn |
| Sep 30, 2021 | 25.41 Mn |